Manage Your Liver
Q:

Hep C News: Only heading in a new direction of treatment will help prevent deaths

Hep C News: Only heading in a new direction of treatment will help prevent deaths
A:

Recent data released by the Centre for Disease Control and Prevention (CDC) showed that the deaths associated with hepatitis C reached an all-time high of 19,659 in 2014. Since 2013, the annual hepatitis C-related mortality surpassed the total combined number of deaths from 60 other infectious diseases. [1]

 

Although the effectiveness of  the recently introduced hepatitis C antiviral treatment (DAA) is higher than previous drugs, this new treatment does not directly reduce liver damage nor improve liver health. [2] Together with the data released by CDC, it is suggested that the DAA treatments are not able to lower the number of deaths related to hepatitis C.

 

The only function of antiviral drugs is to eliminate the hepatitis virus in the human body, thus, to regain liver health, the liver must recover itself using its unique self-repairing ability. However using drugs actually causes further damage to the liver as the drug itself contains toxicity. A recent published paper has found that using DAA treatment might have an impact on the immune system as there is a sudden change of viral count, thus dramatically increasing the risk of liver cancer. [3] The number of related deaths caused by hepatitis C is continuously increasing; this is a clear indication that it is time to reconsider current treatment direction.

 

From the patients’ point of view, the primary objective of treatment should be to ensure normal liver function (ALT level), to reduce and prevent liver fibrosis, and to improve the quality of daily life. Only by successfully carrying out these objectives can one ensure long term liver health protection, reduce the likelihood of severe liver diseases and lower the risk of deaths caused by liver inflammation related diseases.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hep CHepatitis CDAA treatmentDeath rate
Related Questions
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
A recent study by Cancer Research reveal that obesity and diabetes increases the risks of liver cancer.   Liver cancer is ranked at sixth most common type of cancer, the number of liver cancers has tripled since the 70s in the United States. Liver cancers is mainly due to hepatitis C, NAFLD (non alcoholic fatty liver disease), and NASH. It is often hard to treat because symptoms are vague and it may be spotted too late to be treated effectively.  
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us